Old Web
English
Sign In
Acemap
>
Paper
>
Cost-Effectiveness of Pixantrone for the Third-/Fourth-Line Treatment of Aggressive Non-Hodgkin’s Lymphoma in Portugal
Cost-Effectiveness of Pixantrone for the Third-/Fourth-Line Treatment of Aggressive Non-Hodgkin’s Lymphoma in Portugal
2016
J Félix
B. Vandewalle
V. Andreozzi
Jazon Romilson de Souza Almeida
Nice Maria Oliveira da Silva
C. Ferreira
D.M.S. Ferreira
A. Amorim
D. Doering
N. Branscombe
Keywords:
Intensive care medicine
Pixantrone
Non-Hodgkin's lymphoma
Medicine
cost effectiveness
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]